Health
AstraZeneca COVID-19 vaccine shows promise in elderly – Sydney Morning Herald
AstraZeneca and Oxford University researchers expect to release full late-stage trial results by Christmas.
Late-stage, or Phase III, trials are ongoing to confirm the findings, researchers said, and to test whether the vaccine protects against infection with SARS-CoV-2 in a broad range of people, including people with underlying health conditions.
Results of those trials should be known by Christmas, the Oxford Vaccine Group’s director Andrew Pollard said, adding it was too early to know whether and how well the vaccine works in actually preventing COVID-19.
“We haven’t quite got to that point yet. We’re…
-
Business9 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
Noosa News23 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General21 hours agoDonald Trump and the ghost of Al Capone • Inside Story